According to the pharmaceutical industry, in Britain “companies work closely with the authorities and drug development is faster”
The transfer of cancer research to Britain was announced by German pharmaceutical company BioNTech, the company that developed the first mRNA technology vaccine against COVID-19.
The company, according to its co-founders, considers the conditions in Britain more favorable for pharmaceutical research. “Companies work closely with authorities and drug development is faster. BioNTech is based on the strengths of each country in terms of research and drug development,” said Ezlem Toureji, one of the company’s founders, to BILD and added that from now on it will be extremely important to create ecosystems favorable to research. “This applies, among other things, to the funding of research and its faster translation into application, the promotion of biotech ecosystems in Europe and the corresponding regulations and guidelines,” he said.
According to the newspaper, BioNTech joins a number of German high-tech companies that are leaving not only Germany, but also the European Union, in search of more favorable conditions. Indicatively, Bayer intends to transfer a large part of its activity to China and the USA, because “Europe is not friendly to innovation”.
Chemical industry BASF is building a factory in China, which poses an immediate risk to the 39,000 jobs at the Ludwigshafen plant. The company cites high energy prices, red tape and high social security costs in Germany for its move.
Indicative of the deterioration of the business environment is, according to a study by the Family Business Foundation, Germany’s ranking in 18th place in terms of competitiveness, among the 21 strongest economies worldwide. In 2020, Germany was in 14th place.
The question of competitiveness is of particular concern to the federal government, especially after the implementation of anti-inflationary measures by the US, which make it more attractive for companies to leave Europe and locate in the US.
RES-EMP
Read the News today and get the latest news.
Follow Skai.gr on Google News and be the first to know all the news.
I am Terrance Carlson, author at News Bulletin 247. I mostly cover technology news and I have been working in this field for a long time. I have a lot of experience and I am highly knowledgeable in this area. I am a very reliable source of information and I always make sure to provide accurate news to my readers.
